In the past few years, the wide application of cardiac magnetic resonance (CMR)
significantly changed the approach to the study of cardiac involvement in Fabry Disease …

Abstract Introduction About 50% of Fabry disease (FD) patients develop cardiac
manifestation, also known as Fabry cardiomyopathy. Beside echocardiography, cardiac …

Background Cardiovascular magnetic resonance (CMR) can measure cardiac structure,
function and characterize myocardial tissue. The full potential of CMR for Fabry disease (FD) …

Fabry disease (FD) is a rare genetic X-linked disorder that can impact multiple organs.
Cardiac involvement influences the prognosis of patients with FD, being one of the main …

Abstract Funding Acknowledgements Type of funding sources: None. Background Staging
of Fabry disease (FD) cardiomyopathy uses multiparametric cardiac MRI. Advanced disease …

Cardiac involvement is a common and significant source of morbidity and mortality in Fabry
disease (FD). The severity of cardiac involvement can vary widely among patients, making it …

Fabry disease (FD) causes myocardial native T1 lowering on cardiac magnetic resonance
(CMR), left ventricular hypertrophy (LVH), and late gadolinium enhancement (LGE). LVH is …

Background Cardiac involvement is a major contributor of morbidity and mortality in Fabry
disease (FD). Early detection and accurate evaluation of the disease progression is …

Background The assessment of late gadolinium enhancement (LGE) and left ventricular
hypertrophy (LVH) by cardiac magnetic resonance (CMR) as diagnostic and prognostic …

Background Initiation of enzyme replacement therapy (ERT) early in the Fabry disease
course may facilitate better outcomes than in patients with advanced disease. Early …